Deenanath Mangeshkar Hospital & Research Centre   Report issue

Academic/Hospital Phase 2 Phase 3
Founded: Pune India (1989)

Organization Overview

First Clinical Trial
2008
NCT00824343
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2014

Timeline

NOW
  • Now

Alternative names

Deenanath Mangeshkar Hospital and Research Centre, Erandwane, Pune - 411004 | Deenanath Mangeshkar Hospital & Research Centre, ,Pune, India | Medical Oncologist, Deenanath Mangeshkar Hospital and Research Centre, Pune, India

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Carcinoma (Phase 2)

Carcinoma, Squamous Cell (Phase 2)

Communicable Diseases (Phase 3)

Diabetes Mellitus (Phase 2)

Diabetes Mellitus, Type 2 (Phase 2)

Infections (Phase 3)

Pancreatic Neoplasms (Phase 2)

Pyelonephritis (Phase 3)

Squamous Cell Carcinoma of Head and Neck (Phase 2)

Urinary Tract Infections (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 4
  • # of Trial APIs: 8